Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes
© Hashioka et al.; licensee BioMed Central Ltd. 2014
Received: 5 July 2013
Accepted: 15 January 2014
Published: 22 January 2014
The properties of Ca2+ signaling mediated by purinergic receptors are intrinsically linked with functional activity of astrocytes. At present little is known concerning Ca2+-dependent purinergic responses in adult human astrocytes. This work has examined effects of purinergic stimulation to alter levels of intracellular Ca2+ in adult human astrocytes. Ca2+-sensitive spectrofluorometry was carried out to determine mobilization of intracellular Ca2+ following adenosine triphosphate (ATP) or 3′-O-(4-benzoyl)benzoyl-ATP (Bz-ATP) stimulation of adult human astrocytes. In some experiments pharmacological modulation of Ca2+ pathways was applied to help elucidate mechanisms of Ca2+ signaling. RT-PCR was also performed to confirm human astrocyte expression of specific purinoceptors which were indicated from imaging studies.
The endogenous P2 receptor agonist ATP (at 100 μM or 1 mM) applied in physiological saline solution (PSS) evoked a rapid increase of [Ca2+]i to a peak amplitude with the decay phase of response exhibiting two components. The two phases of decay consisted of an initial rapid component which was followed by a secondary slower component. In the presence of Ca2+-free solution, the secondary phase of decay was absent indicating this prolonged component was due to influx of Ca2+. This prolonged phase of decay was also attenuated with the store-operated channel (SOC) inhibitor gadolinium (at 2 μM) added to standard PSS, suggesting this component was mediated by SOC activation. These results are consistent with ATP activation of P2Y receptor (P2YR) in adult human astrocytes leading to respective rapid [Ca2+]i mobilization from intracellular stores followed by Ca2+ entry through SOC. An agonist for P2X7 receptor (P2X7R), BzATP induced a very different response compared with ATP whereby BzATP (at 300 μM) elicited a slowly rising increase in [Ca2+]i to a plateau level which was sustained in duration. The BzATP-induced increase in [Ca2+]i was not enhanced with lipopolysaccharide pre-treatment of cells as previously found for P2X7R mediated response in human microglia. RT-PCR analysis showed that adult human astrocytes in vitro constitutively express mRNA for P2Y1R, P2Y2R and P2X7R.
These results suggest that activation of metabotropic P2YR (P2Y1R and/or P2Y2R) and ionotropic P2X7R could mediate purinergic responses in adult human astrocytes.
Astrocytes respond to a variety of physiological and pathological stimuli with an increase in intracellular Ca2+ concentration ([Ca2+]i), often referred to as “Ca2+ signaling” or “Ca2+ excitability” [1, 2]. Astrocyte functional processes are intricately linked to, and shaped by, activation of particular purinergic receptors. Adenosine triphosphate (ATP) is one of the primary extracellular signaling molecules for astrocytes under both physiological and pathological conditions and evokes an astrocytic [Ca2+]i elevation through activation of P2 purinoceptors . P2 purinoceptors are subdivided into two families consisting of metabotropic P2Y receptor (P2YR) and ionotropic P2X receptor (P2XR). In the former case subtypes of P2YR, such as P2Y1R and P2Y2R, are G-protein coupled and linked to inositol triphosphate-mediated release of Ca2+ from intracellular endoplasmic reticulum (ER) stores [3–5].
Activation of purinergic receptors alters Ca2+-dependent pathways and intracellular levels of Ca2+ which in turn determine cellular functional responses to endogenous ligand, ATP. For example, ATP stimulation of P2YR not only mobilizes [Ca2+]i from stores but also leads to influx of Ca2+ through store-operated channels (SOC) subsequent to store depletion. An alternative pathway for entry of Ca2+ from extracellular medium is provided by activation of family members of P2XR ionotropic channels. Overall, a diversity of astrocyte functional responses such as cellular growth and proliferation, cytokine production and regulation of cerebral blood flow can depend on the characteristics of Ca2+ signaling in cells [2, 6, 7].
At present, few studies have addressed the expression and properties of Ca2+ signaling in adult human astrocytes compared with work on rodent astrocytes. Furthermore, the majority of studies on human astrocytes have involved use of fetal cells. Specific properties and activity of astrocytes could differ depending on their species as well as ages. For example, human astrocytes are substantially larger, more complex and propagate Ca2+ signals significantly faster than their rodent counterparts . In humans, adult astrocytes have been reported to proliferate at much lower rate than fetal cells and not to recapitulate the in vitro differentiation . The manner of Ca2+ signaling mediated by purinoceptor activation in adult human astrocytes may have significance in determining astrocyte characteristics, including expression of neurotransmitter receptors, ion channels, transporters and gap junction proteins.
The main purpose of this study was to characterize Ca2+ signaling pathways in adult human astrocytes following activation of purinergic receptors. Calcium-sensitive fluorescence spectroscopy has been used to determine P2YR and P2XR contributions to [Ca2+]i mobilization in stimulated cells. In addition, reverse transcription polymerase chain reaction (RT-PCR) has indicated the expression of P2Y1R, P2Y2R and P2X7R in the adult human cells. To our knowledge, this work is the first report describing changes in intracellular Ca2+ mobilization associated with activation of purinergic receptors in primary culture of adult human astrocytes.
Chemicals and reagents
ATP, 3′-O-(4-benzoyl)benzoyl-ATP (BzATP), lipopolysaccharide (LPS), gadolinium and dimethyl sulfoxide (DMSO) were obtained from Sigma-Aldrich (St. Louis, MO). ATP and BzATP were dissolved in PBS solution. Fura-2/AM (F-1221) was purchased from Invitrogen Canada (Burlington, ON) and dissolved in DMSO.
Adult human astrocytes were obtained from epileptic patients undergoing temporal lobe surgery with consents of all patients. Normal brain tissues overlying the epileptic foci were obtained from a standard elective surgical procedure where, in order to remove an epileptic focus, the surgeon first removed normal brain tissue which lies superficial to the previously defined epileptic focus. The epileptic patients were a 27 year-old male, 31 year-old female, 36 year-old female and 41 year-old male. Every brain sample arrived at our laboratory within 24 h after surgery and was immediately used for astrocyte isolation. The use of human brain materials was approved by the Clinical Research Ethics Board for Human Subjects of the University of British Columbia.
Astrocytes were isolated as described previously [10, 11]. They were grown in Dulbecco’s modified Eagle medium-nutrient mixture F12 Ham (DMEM-F12) supplemented with 10% fetal bovine serum and penicillin (200 U/ml)/streptomycin (200 μg/ml) (all from Invitrogen Canada). Astrocytes were cultured for 3-4 weeks before performing assays. Purity of astrocyte culture was estimated by fluorescent immunocytochemistry with the astrocytic marker glial fibrillar acidic protein (GFAP) (Z334, Dako, Denmark) and counterstaining nuclei with Hoechst 33258 (Hoechst, Frankfurt, Germany). Visualization was achieved using the Alexa Fluor 546 (Invitrogen Canada)-conjugated secondary antibody and a fluorescence microscope (Olympus, BX-51, Tokyo, Japan). Under our culture conditions, more than 99% cells were positive for GFAP in astrocytic culture.
A previous procedure established for measurement of intracellular Ca2+ [12–15] was modified and followed. In brief, 2-5 × 105 of astrocytes plated on 22-mm coverslips (Deckglaser, Sondheim, Germany) were incubated with the fluorescent Ca2+ indicator Fura-2/AM (at 1 μM) plus pluronic acid (at 1 μM) in normal physiological saline solution (PSS) for 20 min at 37°C. PSS contained (in mM): NaCl (126), KCl (5), MgCl2 (1.2), HEPES (10), D-glucose (10) and CaCl2 (1); pH of 7.4. In some experiments, Ca2+-free PSS was used; this solution had the same composition as PSS except that 1 mM of EGTA was added instead of CaCl2. All reagents used in this assay were obtained from Sigma-Aldrich (St. Louis, MO). After a 20-minute wash in dye-free PSS at 37°C, coverslips were placed on the stage of an inverted microscope equipped with a 40× objective (Axiovert, Zeiss, Oberkochen, Germany). Cells were exposed to alternating wavelengths of 340 nm and 380 nm for excitation at 6-second intervals. Emission light was passed through a 510-nm filter. An imaging system (Empix Imaging, Mississauga, ON, Canada) was used to record fluorescence ratios using a CCD camera (DVC-1310, DVC Company Inc., Austin, TX). The bath chamber was designed to maintain a constant bath volume and standard saline PSS was used to rinse the bath immediately prior to experiments. The bath solution was static with the exception of changes in solution, applied within 60 s after PSS rinse, and associated with the addition or removal of agonists and antagonists. Responses to purinergic application are presented as fluorescence intensity ratios at excitation wavelengths of 340 to 380 nm (F340/380) versus time with all experiments performed at room temperature. Amplitudes of all responses in this study are described as ratiometric values derived from the ratio of excitation wavelengths.
ATP-induced responses exhibited fast and slow components of decay. The time course of the rapid initial decay was measured at a point at half-amplitude of peak response. The time course of the secondary slower phase of decay was measured at half-amplitude of this component. The height of the prolonged phase was determined as the point of intersection of the component with time at peak response. ATP response in Ca2+-free PSS or in standard Ca2+ solution containing Gd3+ showed single phase decays from a peak value with time courses determined at half-amplitude values of peak. BzATP-induced response consisted of a single phase of a slowly developing increase to a peak level with amplitude of fluorescent ratio used as a measure of response.
Primary human astrocytes were seeded onto 6-well plates (4 × 105 cells per well in 2 ml total volume) in DMEM/F12 containing 10% fetal bovine serum. After 48 h, total RNA was isolated using a commercially available kit according to the manufacturer’s instructions for adherent cells (Aurum™ Total RNA Mini Kit, Bio-Rad Laboratories, Inc., Hercules, CA). RNA concentration was measured using a spectrophotometer and purity ensured by 260/280 nm ratio of >1.95 for all samples. cDNA was reverse-transcribed using the qScript™ cDNA Synthesis Kit from Quanta Biosciences (Gaithersburg, MD). PCR amplification of cDNA was performed as described previously  using GoTaq Green Master Mix (Promega, Madison, WI) on a Bio-Rad C1000 Thermal Cycler. Previously published primer sequences were used: P2Y1 ; Forward: 5′ - GAC TTC TTG TAC GTG CTG ACT CT - 3′; Reverse: 5′ - GAC CTC TTG TCA CCT GAT ACG TG - 3′; product size: 647 bp, P2Y2 ; Forward: 5′ - CTC TAC TTT GTC ACC ACC AG - 3′; Reverse: 5′ - TTC TGC TCC TAC AGC CGA AT - 3′; product size: 638 bp, and P2X7 ; Forward: 5′ – TCC GAG AAA CAG GCG ATA A- 3′; Reverse: 5′ – ACT CGC ACT TCT TCC TGT A - 3′; product size: 465 bp. PCR conditions consisted of an initial denaturation step at 95°C for 2 min, followed by 40 cycles of 30 s denaturation step at 95°C, 30 s annealing step at 53.5°C (P2Y1 and P2X7) or 56.5°C (P2Y2), and 1 min extension step at 72°C. A final extension step of 5 min at 72°C was also performed. PCR products were separated by electrophoresis on a 1% agarose gel and visualized with SYBR safe DNA gel stain (Invitrogen, Eugene, OR). Digital photographs of the gels were taken with the Fluorchem FC2 imaging and image analysis system from Alpha Innotech (Santa Clara, CA). All PCR results were derived with cycle number producing a signal in the linear portion of the amplification curve.
Data are presented as means ± standard error of mean (SEM). Statistical significance was determined using one-way analysis of variance (ANOVA) followed by Student-Newman-Keuls multiple comparison test. P < 0.05 was considered statistically significant.
ATP-induced changes in [Ca2+]i
Physiological and pharmacological protocols were used to examine modulation of Ca2+ entry into adult human astrocytes using application of 1 mM ATP. In one set of experiments, extracellular Ca2+ was replaced with Ca2+-free PSS to prevent influx of Ca2+ as a contributing mechanism for changes in [Ca2+]i. A typical astrocytic response induced by ATP in Ca2+-free PSS is presented in Figure 2C. It showed a single declining phase with no prolonged component of decay. The absence of the delayed phase of [Ca2+]i in Ca2+-free solution is consistent with influx of extracellular Ca2+ mediating this component of response. In three additional experiments, the secondary slow phase of response was absent in Ca2+-free solution. Overall results (N = 4 experiments, total of 85 cells) yielded a single time course of decay in Ca2+-free PSS was 28.9 ± 1.8 s. This decay time course was not significantly different (p > 0.05) from the rapid time course of the control response evoked by 1 mM ATP (Figure 2A).
The prolonged phase of [Ca2+]i elicited by ATP in standard PSS (Figure 2A, B) and its absence in Ca2+-free PSS (Figure 2C) could reflect entry of Ca2+ through SOC following the initial release of the divalent ion from internal stores. To investigate this possibility, ATP-induced responses were studied with 2 μM of gadolinium (Gd3+) added to standard PSS. Inhibition of SOC with Gd3+ has previously been demonstrated in a variety of cell types, including smooth muscle and glioma cells [14, 20]. A representative response is shown in Figure 2D for the [Ca2+]i change induced by 1 mM ATP in human astrocytes exposed to Gd3+. A single monophasic time course of decay for [Ca2+]i was observed, indicating that addition of Gd3+ to standard PSS inhibits the prolonged component of the ATP response. Overall (N = 4 experiments, total of 79 cells), ATP induced a single time course of decay with mean value of 29.3 ± 5.2 s when Gd3+ was added to PSS. This time course of response was not significantly different (p > 0.05) from the rapid phase of decay in control induced by 1 mM ATP (Figure 2A).
BzATP-induced changes in [Ca2+]i
Previous work has demonstrated LPS priming of BzATP responses, measured as amplitudes of fluorescent ratio, in microglia which was attributed to inflammatory enhancement in numbers of P2X7R . This finding prompted us to examine LPS as a modulatory agent for purinergic response in adult human astrocytes. LPS pretreatment (100 ng/ml for 16 h) was used as an inflammatory stimulus for adult human astrocytes. Figure 3B shows a representative change in [Ca2+]i induced by BzATP for cells administered LPS treatment. Overall (N = 4 experiments, total of 49 cells), the amplitude of the BzATP-induced response was 0.24 ± 0.03 with LPS treatment compared with an amplitude of 0.21 ± 0.02 in the absence of LPS treatment. This difference was not significant (p > 0.05) indicating LPS was ineffective as a modulatory stimulus to enhance purinergic responses to BzATP in adult human astrocytes.
Expression of P2Y1R, P2Y2R and P2X7R in adult human astrocytes
To our knowledge, this is the first study that demonstrates intracellular Ca2+ mobilization following activation of purinergic receptors in cultures of primary adult human astrocytes. We report ATP induction of intracellular Ca2+ mobilization mediated by depletion of intracellular stores consistent with activation of metabotropic P2YR in adult human astrocytes. This component of [Ca2+]i change is followed by a subsequent influx of Ca2+ through SOC. RT-PCR analysis demonstrated the expression of specific subtype metabotropic P2Y1R and P2Y2R in addition to ionotropic P2X7R. Interestingly, this expression pattern of P2 purinoceptor in adult human astrocytes is consistent with observations made in fetal human  and newborn rat  astrocytes.
ATP stimulation of adult human astrocytes mobilized intracellular Ca2+ with a response characterized by two components of decay. The initial rapid transient component following peak response is consistent with activation of metabotropic P2YR and mediated by Ca2+ release from ER stores independent of extracellular Ca2+ [4, 14]. The subsequent prolonged component was considerably attenuated with ATP application in Ca2+-free PSS, indicating this phase of response was due to Ca2+ influx through plasmalemmal membrane . This secondary component of response likely represents Ca2+ entry through SOC since the component was inhibited in the presence of the SOC antagonist, Gd3+ [14, 20]. The single time courses of [Ca2+]i elicited by ATP in Ca2+-free and in Gd3+ with standard Ca2+ PSS (200 s treatment) were similar in magnitude (near 29 s) and somewhat longer than the rapid phase evoked by ATP in standard Ca2+ solution. This result suggests that only a partial inhibition of SOC was attained with astrocytes exposed to 2 μM Gd3+ for a duration 200 s. A possible explanation for the longer time course of decay in Ca2+-free PSS, relative to the rapid phase of control ATP response in PSS, is that residual Ca2+ could remain in nominally Ca2+-free solution. In order to minimize effects of non-physiological Ca2+-free PSS on cell viability, we employed relatively short treatment times of 60 s with this solution prior to ATP stimulation. We did not test Gd3+ at concentrations higher than 2 μM nor increase incubation time with Ca2+-free PSS to detect astrocytic responses in a robust and healthy condition. The overall results from calcium imaging experiments suggest that purinergic response to endogenous ligand in adult human astrocytes is mediated by ATP binding to metabotropic P2YR with subsequent mobilization of [Ca2+]i due to intracellular release and influx through SOC.
Ca2+ spectrofluorometry showed that application of BzATP elicited a gradual and sustained increase in [Ca2+]i in adult human astrocytes. This finding suggests influx of Ca2+ through the nonselective cationic channel coupled to activation of P2X7R [1, 4] and is consistent with previous work demonstrating a modest and prolonged [Ca2+]i rise elicited by BzATP in fetal human astrocytes .
Purinergic agonists and antagonists are notorious for non-specific activity [23, 24]. Although BzATP has been reported as an activator of P2X7R in numerous studies [12, 13, 15, 25], considerable non-specificity of the ligand has also been documented. Examples include actions of BzATP mediated by ionotropic P2X1 and P2X3  and metabotropic P2Y2  receptors. Recent work on rodent cerebellar astrocytes has demonstrated calcium responses mediated by P2Y13 receptors in addition to P2X7R activation . In addition, BzATP responses have been attributed to activation of adenosine receptors, an effect involving dephosphorylation activity of ecto-nucleotidases . It should also be noted that interpretation of BzATP-induced responses is further complicated by the variability in actions of P2X7R antagonists with Brilliant blue G  exhibiting a greater selectivity for P2X7R inhibitory activity compared with oxidized ATP . Overall, a multiplicity of purinergic receptors could contribute to BzATP responses in addition to the activation of P2X7R.
We found that LPS priming of human astrocytes (100 ng/ml for 16 h) had no significant effect to alter amplitude of BzATP-induced responses compared with controls (no LPS pretreatment). Interestingly, this result is in contrast to previous findings on fetal human microglia which demonstrated that exposure of cells to LPS (100 ng/ml for 2 h) significantly enhanced the amplitude of BzATP-evoked [Ca2+]i . One possibility for the differences of LPS treatment on Ca2+ mobilization in astrocytes and microglia may be related to differential cellular expression of receptors for LPS. In particular CD14, a putative LPS receptor, is not expressed in human astrocytes  whereas this receptor is expressed in human microglia, the resident immune responding cells in brain .
Our study has presented novel findings concerning expression and activation of specific purinergic Ca2+ signaling pathways in cultured adult human astrocytes. Metabotropic P2YR and ionotropic P2XR are putative mediators of purinergic responses in the cells. Future studies using adult human astrocytes are warranted to characterize the specific roles of the purinergic receptors in mediating cellular responses. Such work will enable clarification of downstream Ca2+-dependent and independent signaling pathways. P2X7R expression and function should be confirmed in these cells followed by examination of roles of the receptor in mediating astrocytic responses in pathological microenvironments in human brain.
This research was supported by the Pacific Alzheimer Research Foundation (SH, PLM and JGM), Grant-in-Aid for Scientific Research #24591721 (SH) and the Jack Brown and Family Alzheimer’s Disease Research Foundation (JPL and AK).
- Butt AM: ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin Cell Dev Biol. 2011, 22: 205-213. 10.1016/j.semcdb.2011.02.023.View ArticlePubMedGoogle Scholar
- James G, Butt AM: P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol. 2002, 447: 247-260. 10.1016/S0014-2999(02)01756-9.View ArticlePubMedGoogle Scholar
- Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA: International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006, 58: 281-341. 10.1124/pr.58.3.3.PubMed CentralView ArticlePubMedGoogle Scholar
- McLarnon JG: Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res. 2005, 81: 349-356. 10.1002/jnr.20475.View ArticlePubMedGoogle Scholar
- Neary JT, Zimmermann H: Trophic functions of nucleotides in the central nervous system. Trends Neurosci. 2009, 32: 189-198. 10.1016/j.tins.2009.01.002.View ArticlePubMedGoogle Scholar
- Mulligan SJ, MacVicar BA: Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature. 2004, 431: 195-199. 10.1038/nature02827.View ArticlePubMedGoogle Scholar
- Straub SV, Nelson MT: Astrocytic calcium signaling: the information currency coupling neuronal activity to the cerebral microcirculation. Trends Cardiovasc Med. 2007, 17: 183-190. 10.1016/j.tcm.2007.05.001.PubMed CentralView ArticlePubMedGoogle Scholar
- Oberheim NA, Goldman SA, Nedergaard M: Heterogeneity of astrocytic form and function. Methods Mol Biol. 2012, 814: 23-45. 10.1007/978-1-61779-452-0_3.PubMed CentralView ArticlePubMedGoogle Scholar
- Sharif A, Prevot V: Isolation and culture of human astrocytes. Methods Mol Biol. 2012, 814: 137-151. 10.1007/978-1-61779-452-0_11.View ArticlePubMedGoogle Scholar
- Hashioka S, Klegeris A, Schwab C, McGeer PL: Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging. 2009, 30: 1924-1935. 10.1016/j.neurobiolaging.2008.02.019.View ArticlePubMedGoogle Scholar
- Hashioka S, Klegeris A, Qing H, McGeer PL: STAT3 inhibitors attenuate interferon-gamma-induced neurotoxicity and inflammatory molecule production by human astrocytes. Neurobiol Dis. 2011, 41: 299-307. 10.1016/j.nbd.2010.09.018.View ArticlePubMedGoogle Scholar
- Choi HB, Hong SH, Ryu JK, Kim SU, McLarnon JG: Differential activation of subtype purinergic receptors modulates Ca(2+) mobilization and COX-2 in human microglia. Glia. 2003, 43: 95-103. 10.1002/glia.10239.View ArticlePubMedGoogle Scholar
- Choi HB, Ryu JK, Kim SU, McLarnon JG: Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J Neurosci. 2007, 27: 4957-4968. 10.1523/JNEUROSCI.5417-06.2007.View ArticlePubMedGoogle Scholar
- Jantaratnotai N, Choi HB, McLarnon JG: ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells. BMC Cancer. 2009, 9: 442-10.1186/1471-2407-9-442.PubMed CentralView ArticlePubMedGoogle Scholar
- McLarnon JG, Ryu JK, Walker DG, Choi HB: Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J Neuropathol Exp Neurol. 2006, 65: 1090-1097. 10.1097/01.jnen.0000240470.97295.d3.View ArticlePubMedGoogle Scholar
- Villanueva EB, Little JP, Lambeau G, Klegeris A: Secreted phospholipase A(2) group IIA is a neurotoxin released by stimulated human glial cells. Mol Cell Neurosci. 2012, 49: 430-438. 10.1016/j.mcn.2012.02.006.View ArticlePubMedGoogle Scholar
- John GR, Simpson JE, Woodroofe MN, Lee SC, Brosnan CF: Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression. J Neurosci. 2001, 21: 4134-4142.PubMedGoogle Scholar
- Adrian K, Bernhard MK, Breitinger HG, Ogilvie A: Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells. Biochim Biophys Acta. 2000, 1492: 127-138. 10.1016/S0167-4781(00)00094-4.View ArticlePubMedGoogle Scholar
- Budagian V, Bulanova E, Brovko L, Orinska Z, Fayad R, Paus R, Bulfone-Paus S: Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem. 2003, 278: 1549-1560. 10.1074/jbc.M206383200.View ArticlePubMedGoogle Scholar
- Flemming R, Xu SZ, Beech DJ: Pharmacological profile of store-operated channels in cerebral arteriolar smooth muscle cells. Br J Pharmacol. 2003, 139: 955-965. 10.1038/sj.bjp.0705327.PubMed CentralView ArticlePubMedGoogle Scholar
- Narcisse L, Scemes E, Zhao Y, Lee SC, Brosnan CF: The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia. 2005, 49: 245-258. 10.1002/glia.20110.PubMed CentralView ArticlePubMedGoogle Scholar
- Jimenez AI, Castro E, Communi D, Boeynaems JM, Delicado EG, Miras-Portugal MT: Coexpression of several types of metabotropic nucleotide receptors in single cerebellar astrocytes. J Neurochem. 2000, 75: 2071-2079.View ArticlePubMedGoogle Scholar
- Anderson CM, Nedergaard M: Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci. 2006, 29: 257-262. 10.1016/j.tins.2006.03.003.View ArticlePubMedGoogle Scholar
- North RA: Molecular physiology of P2X receptors. Physiol Rev. 2002, 82: 1013-1067.View ArticlePubMedGoogle Scholar
- Ryu JK, Jantaratnotai N, Serrano-Perez MC, McGeer PL, McLarnon JG: Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model. J Neuropathol Exp Neurol. 2011, 70: 13-22. 10.1097/NEN.0b013e318201d4d4.View ArticlePubMedGoogle Scholar
- Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, Park HS, Yu H, Metzger R, Kowaluk E, et al: Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol. 1999, 376: 127-138. 10.1016/S0014-2999(99)00350-7.View ArticlePubMedGoogle Scholar
- Fedorov IV, Rogachevskaja OA, Kolesnikov SS: Modeling P2Y receptor-Ca2+ response coupling in taste cells. Biochim Biophys Acta. 2007, 1768: 1727-1740. 10.1016/j.bbamem.2007.04.002.View ArticlePubMedGoogle Scholar
- Carrasquero LM, Delicado EG, Bustillo D, Gutierrez-Martin Y, Artalejo AR, Miras-Portugal MT: P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. J Neurochem. 2009, 110: 879-889. 10.1111/j.1471-4159.2009.06179.x.View ArticlePubMedGoogle Scholar
- Kukley M, Stausberg P, Adelmann G, Chessell IP, Dietrich D: Ecto-nucleotidases and nucleoside transporters mediate activation of adenosine receptors on hippocampal mossy fibers by P2X7 receptor agonist 2′-3′-O-(4-benzoylbenzoyl)-ATP. J Neurosci. 2004, 24: 7128-7139. 10.1523/JNEUROSCI.2093-04.2004.View ArticlePubMedGoogle Scholar
- Jiang LH, Mackenzie AB, North RA, Surprenant A: Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol. 2000, 58: 82-88.PubMedGoogle Scholar
- Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A: Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol. 1995, 48: 178-183.PubMedGoogle Scholar
- Farina C, Aloisi F, Meinl E: Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28: 138-145. 10.1016/j.it.2007.01.005.View ArticlePubMedGoogle Scholar
- Lambert C, Desbarats J, Arbour N, Hall JA, Olivier A, Bar-Or A, Antel JP: Dendritic cell differentiation signals induce anti-inflammatory properties in human adult microglia. J Immunol. 2008, 181: 8288-8297.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.